[Virushepatitis and panmyelophthisis].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000750:Anemia, Myelophthisic / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D000818:Animals; D001327:Autoimmune Diseases; D001706:Biopsy; D001711:Biotransformation; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects; D002908:Chronic Disease; D005260:Female; D005859:Germany, East; D005938:Glucocorticoids / Q000009:adverse effects; D006506:Hepatitis A / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008875:Middle Aged; D012737:Sex Factors
D005938:Glucocorticoids; D002701:Chloramphenicol
Zur Beziehung von Virushepatitis und Panmyelophthise.